APO Research
Talk to an analyst

APO RESEARCH · REPORT

Neuropeptide Y Receptor Type 2

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Neuropeptide Y Receptor Type 2 Industry Growth and Trends Forecast to 2032

19 December 202573 pages

Choose your research edition.

Industry ResearchNeuropeptide Y Receptor Type 2 Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Neuropeptide Y Receptor Type 2 Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Neuropeptide Y Receptor Type 2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neuropeptide Y Receptor Type 2 Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Neuropeptide Y Receptor Type 2 Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Neuropeptide Y Receptor Type 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Neuropeptide Y Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Neuropeptide Y Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neuropeptide Y Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Neuropeptide Y Receptor Type 2 include Novo Nordisk A/S, XL-protein GmbH and Gila Therapeutics Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Neuropeptide Y Receptor Type 2 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Neuropeptide Y Receptor Type 2 market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Neuropeptide Y Receptor Type 2 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Neuropeptide Y Receptor Type 2.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Neuropeptide Y Receptor Type 2 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Neuropeptide Y Receptor Type 2 Market by Company

Novo Nordisk A/S

XL-protein GmbH

Gila Therapeutics Inc

Neuropeptide Y Receptor Type 2 Segment by Type

GT-002

NN-9748

XL-310

Others

Neuropeptide Y Receptor Type 2 Segment by Application

Obesity

Epilepsy

Type 2 Diabetes

Others

Neuropeptide Y Receptor Type 2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neuropeptide Y Receptor Type 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neuropeptide Y Receptor Type 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neuropeptide Y Receptor Type 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Neuropeptide Y Receptor Type 2 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Neuropeptide Y Receptor Type 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of GT-002 Table 2. Major Company of NN-9748 Table 3. Major Company of XL-310 Table 4. Major Company of Others Table 5. Global Neuropeptide Y Receptor Type 2 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Neuropeptide Y Receptor Type 2 Sales by Type (2021-2026) & (W Units) Table 7. Global Neuropeptide Y Receptor Type 2 Sales Market Share in Volume by Type (2021-2026) Table 8. Global Neuropeptide Y Receptor Type 2 Sales by Type (2021-2026) & (US$ Million) Table 9. Global Neuropeptide Y Receptor Type 2 Sales Market Share in Value by Type (2021-2026) Table 10. Global Neuropeptide Y Receptor Type 2 Price by Type (2021-2026) & (US$/Unit) Table 11. Global Neuropeptide Y Receptor Type 2 Sales by Type (2027-2032) & (W Units) Table 12. Global Neuropeptide Y Receptor Type 2 Sales Market Share in Volume by Type (2027-2032) Table 13. Global Neuropeptide Y Receptor Type 2 Sales by Type (2027-2032) & (US$ Million) Table 14. Global Neuropeptide Y Receptor Type 2 Sales Market Share in Value by Type (2027-2032) Table 15. Global Neuropeptide Y Receptor Type 2 Price by Type (2027-2032) & (US$/Unit) Table 16. North America Neuropeptide Y Receptor Type 2 Sales by Type (2021-2026) & (W Units) Table 17. North America Neuropeptide Y Receptor Type 2 Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Neuropeptide Y Receptor Type 2 Sales by Type (2021-2026) & (W Units) Table 19. Europe Neuropeptide Y Receptor Type 2 Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Neuropeptide Y Receptor Type 2 Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific Neuropeptide Y Receptor Type 2 Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Neuropeptide Y Receptor Type 2 Sales by Type (2021-2026) & (W Units) Table 23. Latin America Neuropeptide Y Receptor Type 2 Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales by Type (2021-2026) & (US$ Million) Table 26. Neuropeptide Y Receptor Type 2 Industry Trends Table 27. Neuropeptide Y Receptor Type 2 Industry Drivers Table 28. Neuropeptide Y Receptor Type 2 Industry Opportunities and Challenges Table 29. Neuropeptide Y Receptor Type 2 Industry Restraints Table 30. Global Neuropeptide Y Receptor Type 2 Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Neuropeptide Y Receptor Type 2 Revenue Market Share by Company (2021-2026) Table 32. Global Neuropeptide Y Receptor Type 2 Sales by Company (2021-2026) & (W Units) Table 33. Global Neuropeptide Y Receptor Type 2 Sales Share by Company (2021-2026) Table 34. Global Neuropeptide Y Receptor Type 2 Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Neuropeptide Y Receptor Type 2 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Neuropeptide Y Receptor Type 2 Major Company Production Sites and Headquarters Table 37. Global Neuropeptide Y Receptor Type 2 Company, Product Type & Application Table 38. Global Neuropeptide Y Receptor Type 2 Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Neuropeptide Y Receptor Type 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Neuropeptide Y Receptor Type 2 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Neuropeptide Y Receptor Type 2 Sales by Region (2021-2026) & (W Units) Table 43. Global Neuropeptide Y Receptor Type 2 Sales Market Share in Volume by Region (2021-2026) Table 44. Global Neuropeptide Y Receptor Type 2 Sales by Region (2021-2026) & (US$ Million) Table 45. Global Neuropeptide Y Receptor Type 2 Sales Market Share in Value by Region (2021-2026) Table 46. Global Neuropeptide Y Receptor Type 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Neuropeptide Y Receptor Type 2 Sales by Region (2027-2032) & (W Units) Table 48. Global Neuropeptide Y Receptor Type 2 Sales Market Share in Volume by Region (2027-2032) Table 49. Global Neuropeptide Y Receptor Type 2 Sales by Region (2027-2032) & (US$ Million) Table 50. Global Neuropeptide Y Receptor Type 2 Sales Market Share in Value by Region (2027-2032) Table 51. Global Neuropeptide Y Receptor Type 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Neuropeptide Y Receptor Type 2 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Neuropeptide Y Receptor Type 2 Sales by Application (2021-2026) & (W Units) Table 54. Global Neuropeptide Y Receptor Type 2 Sales Market Share in Volume by Application (2021-2026) Table 55. Global Neuropeptide Y Receptor Type 2 Sales by Application (2021-2026) & (US$ Million) Table 56. Global Neuropeptide Y Receptor Type 2 Sales Market Share in Value by Application (2021-2026) Table 57. Global Neuropeptide Y Receptor Type 2 Price by Application (2021-2026) & (US$/Unit) Table 58. Global Neuropeptide Y Receptor Type 2 Sales by Application (2027-2032) & (W Units) Table 59. Global Neuropeptide Y Receptor Type 2 Sales Market Share in Volume by Application (2027-2032) Table 60. Global Neuropeptide Y Receptor Type 2 Sales by Application (2027-2032) & (US$ Million) Table 61. Global Neuropeptide Y Receptor Type 2 Sales Market Share in Value by Application (2027-2032) Table 62. Global Neuropeptide Y Receptor Type 2 Price by Application (2027-2032) & (US$/Unit) Table 63. North America Neuropeptide Y Receptor Type 2 Sales by Application (2021-2026) & (W Units) Table 64. North America Neuropeptide Y Receptor Type 2 Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Neuropeptide Y Receptor Type 2 Sales by Application (2021-2026) & (W Units) Table 66. Europe Neuropeptide Y Receptor Type 2 Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Neuropeptide Y Receptor Type 2 Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific Neuropeptide Y Receptor Type 2 Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Neuropeptide Y Receptor Type 2 Sales by Application (2021-2026) & (W Units) Table 70. Latin America Neuropeptide Y Receptor Type 2 Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales by Application (2021-2026) & (US$ Million) Table 73. Novo Nordisk A/S Company Information Table 74. Novo Nordisk A/S Business Overview Table 75. Novo Nordisk A/S Neuropeptide Y Receptor Type 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Novo Nordisk A/S Neuropeptide Y Receptor Type 2 Product Portfolio Table 77. Novo Nordisk A/S Recent Development Table 78. XL-protein GmbH Company Information Table 79. XL-protein GmbH Business Overview Table 80. XL-protein GmbH Neuropeptide Y Receptor Type 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. XL-protein GmbH Neuropeptide Y Receptor Type 2 Product Portfolio Table 82. XL-protein GmbH Recent Development Table 83. Gila Therapeutics Inc Company Information Table 84. Gila Therapeutics Inc Business Overview Table 85. Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Product Portfolio Table 87. Gila Therapeutics Inc Recent Development Table 88. North America Neuropeptide Y Receptor Type 2 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 89. North America Neuropeptide Y Receptor Type 2 Sales by Country (2021-2026) & (W Units) Table 90. North America Neuropeptide Y Receptor Type 2 Sales Market Share by Country (2021-2026) Table 91. North America Neuropeptide Y Receptor Type 2 Sales Forecast by Country (2027-2032) & (W Units) Table 92. North America Neuropeptide Y Receptor Type 2 Sales Market Share Forecast by Country (2027-2032) Table 93. North America Neuropeptide Y Receptor Type 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. North America Neuropeptide Y Receptor Type 2 Market Size by Country (2021-2026) & (US$ Million) Table 95. North America Neuropeptide Y Receptor Type 2 Market Share by Country (2021-2026) Table 96. North America Neuropeptide Y Receptor Type 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. North America Neuropeptide Y Receptor Type 2 Market Share Forecast by Country (2027-2032) Table 98. Europe Neuropeptide Y Receptor Type 2 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 99. Europe Neuropeptide Y Receptor Type 2 Sales by Country (2021-2026) & (W Units) Table 100. Europe Neuropeptide Y Receptor Type 2 Sales Market Share by Country (2021-2026) Table 101. Europe Neuropeptide Y Receptor Type 2 Sales Forecast by Country (2027-2032) & (W Units) Table 102. Europe Neuropeptide Y Receptor Type 2 Sales Market Share Forecast by Country (2027-2032) Table 103. Europe Neuropeptide Y Receptor Type 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Neuropeptide Y Receptor Type 2 Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Neuropeptide Y Receptor Type 2 Market Share by Country (2021-2026) Table 106. Europe Neuropeptide Y Receptor Type 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Neuropeptide Y Receptor Type 2 Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Neuropeptide Y Receptor Type 2 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Neuropeptide Y Receptor Type 2 Sales by Country (2021-2026) & (W Units) Table 110. Asia-Pacific Neuropeptide Y Receptor Type 2 Sales Market Share by Country (2021-2026) Table 111. Asia-Pacific Neuropeptide Y Receptor Type 2 Sales Forecast by Country (2027-2032) & (W Units) Table 112. Asia-Pacific Neuropeptide Y Receptor Type 2 Sales Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Neuropeptide Y Receptor Type 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Neuropeptide Y Receptor Type 2 Market Size by Country (2021-2026) & (US$ Million) Table 115. Asia-Pacific Neuropeptide Y Receptor Type 2 Market Share by Country (2021-2026) Table 116. Asia-Pacific Neuropeptide Y Receptor Type 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Asia-Pacific Neuropeptide Y Receptor Type 2 Market Share Forecast by Country (2027-2032) Table 118. Latin America Neuropeptide Y Receptor Type 2 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 119. Latin America Neuropeptide Y Receptor Type 2 Sales by Country (2021-2026) & (W Units) Table 120. Latin America Neuropeptide Y Receptor Type 2 Sales Market Share by Country (2021-2026) Table 121. Latin America Neuropeptide Y Receptor Type 2 Sales Forecast by Country (2027-2032) & (W Units) Table 122. Latin America Neuropeptide Y Receptor Type 2 Sales Market Share Forecast by Country (2027-2032) Table 123. Latin America Neuropeptide Y Receptor Type 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Latin America Neuropeptide Y Receptor Type 2 Market Size by Country (2021-2026) & (US$ Million) Table 125. Latin America Neuropeptide Y Receptor Type 2 Market Share by Country (2021-2026) Table 126. Latin America Neuropeptide Y Receptor Type 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Latin America Neuropeptide Y Receptor Type 2 Market Share Forecast by Country (2027-2032) Table 128. Middle East and Africa Neuropeptide Y Receptor Type 2 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 129. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales by Country (2021-2026) & (W Units) Table 130. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales Market Share by Country (2021-2026) Table 131. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales Forecast by Country (2027-2032) & (W Units) Table 132. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales Market Share Forecast by Country (2027-2032) Table 133. Middle East and Africa Neuropeptide Y Receptor Type 2 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Middle East and Africa Neuropeptide Y Receptor Type 2 Market Size by Country (2021-2026) & (US$ Million) Table 135. Middle East and Africa Neuropeptide Y Receptor Type 2 Market Share by Country (2021-2026) Table 136. Middle East and Africa Neuropeptide Y Receptor Type 2 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Neuropeptide Y Receptor Type 2 Market Share Forecast by Country (2027-2032) Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Neuropeptide Y Receptor Type 2 Distributors List Table 141. Neuropeptide Y Receptor Type 2 Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Neuropeptide Y Receptor Type 2 Image Figure 2. Global Neuropeptide Y Receptor Type 2 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neuropeptide Y Receptor Type 2 Market Size (2021-2032) & (US$ Million) Figure 4. Global Neuropeptide Y Receptor Type 2 Sales (2021-2032) & (W Units) Figure 5. GT-002 Image Figure 6. Global GT-002 Sales YoY Growth (2021-2032) & (W Units) Figure 7. NN-9748 Image Figure 8. Global NN-9748 Sales YoY Growth (2021-2032) & (W Units) Figure 9. XL-310 Image Figure 10. Global XL-310 Sales YoY Growth (2021-2032) & (W Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global Neuropeptide Y Receptor Type 2 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Neuropeptide Y Receptor Type 2 Market Share by Type 2025 VS 2032 Figure 15. North America Neuropeptide Y Receptor Type 2 Sales Market Share in Volume by Type in 2025 Figure 16. North America Neuropeptide Y Receptor Type 2 Sales Market Share in Value by Type in 2025 Figure 17. Europe Neuropeptide Y Receptor Type 2 Sales Market Share in Volume by Type in 2025 Figure 18. Europe Neuropeptide Y Receptor Type 2 Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Neuropeptide Y Receptor Type 2 Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Neuropeptide Y Receptor Type 2 Sales Market Share in Value by Type in 2025 Figure 21. Latin America Neuropeptide Y Receptor Type 2 Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Neuropeptide Y Receptor Type 2 Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Neuropeptide Y Receptor Type 2 Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Obesity Image Figure 28. Global Obesity Sales YoY Growth (2021-2032) & (W Units) Figure 29. Epilepsy Image Figure 30. Global Epilepsy Sales YoY Growth (2021-2032) & (W Units) Figure 31. Type 2 Diabetes Image Figure 32. Global Type 2 Diabetes Sales YoY Growth (2021-2032) & (W Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 35. Global Neuropeptide Y Receptor Type 2 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Neuropeptide Y Receptor Type 2 Market Share by Application 2025 VS 2032 Figure 37. North America Neuropeptide Y Receptor Type 2 Sales Market Share in Volume by Application in 2025 Figure 38. North America Neuropeptide Y Receptor Type 2 Sales Market Share in Value by Application in 2025 Figure 39. Europe Neuropeptide Y Receptor Type 2 Sales Market Share in Volume by Application in 2025 Figure 40. Europe Neuropeptide Y Receptor Type 2 Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Neuropeptide Y Receptor Type 2 Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Neuropeptide Y Receptor Type 2 Sales Market Share in Value by Application in 2025 Figure 43. Latin America Neuropeptide Y Receptor Type 2 Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Neuropeptide Y Receptor Type 2 Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales Market Share in Value by Application in 2025 Figure 47. North America Neuropeptide Y Receptor Type 2 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. North America Neuropeptide Y Receptor Type 2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Neuropeptide Y Receptor Type 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Neuropeptide Y Receptor Type 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Neuropeptide Y Receptor Type 2 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Europe Neuropeptide Y Receptor Type 2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Neuropeptide Y Receptor Type 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Neuropeptide Y Receptor Type 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Neuropeptide Y Receptor Type 2 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Asia-Pacific Neuropeptide Y Receptor Type 2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Neuropeptide Y Receptor Type 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Neuropeptide Y Receptor Type 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Neuropeptide Y Receptor Type 2 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Latin America Neuropeptide Y Receptor Type 2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Neuropeptide Y Receptor Type 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Neuropeptide Y Receptor Type 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Middle East and Africa Neuropeptide Y Receptor Type 2 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Neuropeptide Y Receptor Type 2 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Neuropeptide Y Receptor Type 2 Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Neuropeptide Y Receptor Type 2 Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Neuropeptide Y Receptor Type 2 Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • GT-002
  • NN-9748
  • XL-310
  • Others
Applications
  • Obesity
  • Epilepsy
  • Type 2 Diabetes
  • Others
Companies covered
  • Novo Nordisk A/S
  • XL-protein GmbH
  • Gila Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Neuropeptide Y Receptor Type 2 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Neuropeptide Y Receptor Type 2 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Neuropeptide Y Receptor Type 2 Market by Type
  6. 1.3.1 GT-002
  7. 1.3.2 NN-9748
  8. 1.3.3 XL-310
  9. 1.3.4 Others
  10. 1.4 Global Neuropeptide Y Receptor Type 2 Market Size by Type
  11. 1.4.1 Global Neuropeptide Y Receptor Type 2 Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Neuropeptide Y Receptor Type 2 Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Neuropeptide Y Receptor Type 2 Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Neuropeptide Y Receptor Type 2 Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Neuropeptide Y Receptor Type 2 Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Neuropeptide Y Receptor Type 2 Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Neuropeptide Y Receptor Type 2 Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Neuropeptide Y Receptor Type 2 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Neuropeptide Y Receptor Type 2 Industry Trends
  2. 2.2 Neuropeptide Y Receptor Type 2 Industry Drivers
  3. 2.3 Neuropeptide Y Receptor Type 2 Industry Opportunities and Challenges
  4. 2.4 Neuropeptide Y Receptor Type 2 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Neuropeptide Y Receptor Type 2 Revenue (2021-2026)
  2. 3.2 Global Top Players by Neuropeptide Y Receptor Type 2 Sales (2021-2026)
  3. 3.3 Global Top Players by Neuropeptide Y Receptor Type 2 Price (2021-2026)
  4. 3.4 Global Neuropeptide Y Receptor Type 2 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Neuropeptide Y Receptor Type 2 Major Company Production Sites & Headquarters
  6. 3.6 Global Neuropeptide Y Receptor Type 2 Company, Product Type & Application
  7. 3.7 Global Neuropeptide Y Receptor Type 2 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Neuropeptide Y Receptor Type 2 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Neuropeptide Y Receptor Type 2 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Neuropeptide Y Receptor Type 2 Tier 1, Tier 2, and Tier 3
4 Neuropeptide Y Receptor Type 2 Regional Status and Outlook
  1. 4.1 Global Neuropeptide Y Receptor Type 2 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Neuropeptide Y Receptor Type 2 Historic Market Size by Region
  3. 4.2.1 Global Neuropeptide Y Receptor Type 2 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Neuropeptide Y Receptor Type 2 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Neuropeptide Y Receptor Type 2 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Neuropeptide Y Receptor Type 2 Forecasted Market Size by Region
  7. 4.3.1 Global Neuropeptide Y Receptor Type 2 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Neuropeptide Y Receptor Type 2 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Neuropeptide Y Receptor Type 2 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Neuropeptide Y Receptor Type 2 by Application
  1. 5.1 Neuropeptide Y Receptor Type 2 Market by Application
  2. 5.1.1 Obesity
  3. 5.1.2 Epilepsy
  4. 5.1.3 Type 2 Diabetes
  5. 5.1.4 Others
  6. 5.2 Global Neuropeptide Y Receptor Type 2 Market Size by Application
  7. 5.2.1 Global Neuropeptide Y Receptor Type 2 Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Neuropeptide Y Receptor Type 2 Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Neuropeptide Y Receptor Type 2 Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Neuropeptide Y Receptor Type 2 Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Neuropeptide Y Receptor Type 2 Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Neuropeptide Y Receptor Type 2 Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Neuropeptide Y Receptor Type 2 Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Neuropeptide Y Receptor Type 2 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novo Nordisk A/S
  2. 6.1.1 Novo Nordisk A/S Company Information
  3. 6.1.2 Novo Nordisk A/S Business Overview
  4. 6.1.3 Novo Nordisk A/S Neuropeptide Y Receptor Type 2 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novo Nordisk A/S Neuropeptide Y Receptor Type 2 Product Portfolio
  6. 6.1.5 Novo Nordisk A/S Recent Developments
  7. 6.2 XL-protein GmbH
  8. 6.2.1 XL-protein GmbH Company Information
  9. 6.2.2 XL-protein GmbH Business Overview
  10. 6.2.3 XL-protein GmbH Neuropeptide Y Receptor Type 2 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 XL-protein GmbH Neuropeptide Y Receptor Type 2 Product Portfolio
  12. 6.2.5 XL-protein GmbH Recent Developments
  13. 6.3 Gila Therapeutics Inc
  14. 6.3.1 Gila Therapeutics Inc Company Information
  15. 6.3.2 Gila Therapeutics Inc Business Overview
  16. 6.3.3 Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Gila Therapeutics Inc Neuropeptide Y Receptor Type 2 Product Portfolio
  18. 6.3.5 Gila Therapeutics Inc Recent Developments
7 North America by Country
  1. 7.1 North America Neuropeptide Y Receptor Type 2 Sales by Country
  2. 7.1.1 North America Neuropeptide Y Receptor Type 2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Neuropeptide Y Receptor Type 2 Sales by Country (2021-2026)
  4. 7.1.3 North America Neuropeptide Y Receptor Type 2 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Neuropeptide Y Receptor Type 2 Market Size by Country
  6. 7.2.1 North America Neuropeptide Y Receptor Type 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Neuropeptide Y Receptor Type 2 Market Size by Country (2021-2026)
  8. 7.2.3 North America Neuropeptide Y Receptor Type 2 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Neuropeptide Y Receptor Type 2 Sales by Country
  2. 8.1.1 Europe Neuropeptide Y Receptor Type 2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Neuropeptide Y Receptor Type 2 Sales by Country (2021-2026)
  4. 8.1.3 Europe Neuropeptide Y Receptor Type 2 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Neuropeptide Y Receptor Type 2 Market Size by Country
  6. 8.2.1 Europe Neuropeptide Y Receptor Type 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Neuropeptide Y Receptor Type 2 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Neuropeptide Y Receptor Type 2 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Neuropeptide Y Receptor Type 2 Sales by Country
  2. 9.1.1 Asia-Pacific Neuropeptide Y Receptor Type 2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Neuropeptide Y Receptor Type 2 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Neuropeptide Y Receptor Type 2 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Neuropeptide Y Receptor Type 2 Market Size by Country
  6. 9.2.1 Asia-Pacific Neuropeptide Y Receptor Type 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Neuropeptide Y Receptor Type 2 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Neuropeptide Y Receptor Type 2 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Neuropeptide Y Receptor Type 2 Sales by Country
  2. 10.1.1 South America Neuropeptide Y Receptor Type 2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Neuropeptide Y Receptor Type 2 Sales by Country (2021-2026)
  4. 10.1.3 South America Neuropeptide Y Receptor Type 2 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Neuropeptide Y Receptor Type 2 Market Size by Country
  6. 10.2.1 South America Neuropeptide Y Receptor Type 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Neuropeptide Y Receptor Type 2 Market Size by Country (2021-2026)
  8. 10.2.3 South America Neuropeptide Y Receptor Type 2 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Neuropeptide Y Receptor Type 2 Sales by Country
  2. 11.1.1 Middle East and Africa Neuropeptide Y Receptor Type 2 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Neuropeptide Y Receptor Type 2 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Neuropeptide Y Receptor Type 2 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Neuropeptide Y Receptor Type 2 Market Size by Country
  6. 11.2.1 Middle East and Africa Neuropeptide Y Receptor Type 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Neuropeptide Y Receptor Type 2 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Neuropeptide Y Receptor Type 2 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Neuropeptide Y Receptor Type 2 Value Chain Analysis
  2. 12.1.1 Neuropeptide Y Receptor Type 2 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Neuropeptide Y Receptor Type 2 Production Mode & Process
  7. 12.2 Neuropeptide Y Receptor Type 2 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Neuropeptide Y Receptor Type 2 Distributors
  10. 12.2.3 Neuropeptide Y Receptor Type 2 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst